Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q88945022 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241121000345.0 | ||
008 | 241121nneanz||abbn n and d | ||
035 | ‡a (WKP)Q88945022 | ||
024 | ‡a 0000-0002-9364-8572 ‡2 orcid | ||
035 | ‡a (OCoLC)Q88945022 | ||
100 | 0 | ‡a Liang Wang ‡c researcher (ORCID 0000-0002-9364-8572) ‡9 en | |
670 | ‡a Author's Advantages of Single-Stranded DNA Over Double-Stranded DNA Library Preparation for Capturing Cell-Free Tumor DNA in Plasma | ||
670 | ‡a Author's Bioinformatics Analysis for Circulating Cell-Free DNA in Cancer | ||
670 | ‡a Author's Cell-free DNA copy number variations in plasma from colorectal cancer patients | ||
670 | ‡a Author's Cell-free DNA methylome profiling by MBD-seq with ultra-low input | ||
670 | ‡a Author's Cell-Free eccDNAs: A New Type of Nucleic Acid Component for Liquid Biopsy? | ||
670 | ‡a Author's CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer | ||
670 | ‡a Author's Exosomal miRNAs as Novel Pharmacodynamic Biomarkers for Cancer Chemopreventive Agent Early Stage Treatments in Chemically Induced Mouse Model of Lung Squamous Cell Carcinoma. | ||
670 | ‡a Author's High-throughput screening of prostate cancer risk loci by single nucleotide polymorphisms sequencing. | ||
670 | ‡a Author's Molecular characterization of cell-free eccDNAs in human plasma. | ||
670 | ‡a Author's Multiplex Digital PCR to Detect Amplifications of Specific Androgen Receptor Loci in Cell-Free DNA for Prognosis of Metastatic Castration-Resistant Prostate Cancer | ||
670 | ‡a Author's NRF2-Driven KEAP1 Transcription in Human Lung Cancer | ||
670 | ‡a Author's PLK1 induces chromosomal instability and overrides cell cycle checkpoints to drive tumorigenesis | ||
670 | ‡a Author's Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients | ||
670 | ‡a Author's Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo | ||
670 | ‡a Author's Single-nucleotide polymorphism rs13426236 contributes to an increased prostate cancer risk via regulating MLPH splicing variant 4 | ||
670 | ‡a Author's Single-Nucleotide Polymorphisms Sequencing Identifies Candidate Functional Variants at Prostate Cancer Risk Loci | ||
670 | ‡a Author's Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer | ||
909 | ‡a (orcid) 0000000293648572 ‡9 1 | ||
919 | ‡a singlenucleotidepolymorphismssequencingidentifiescandidatefunctionalvariantsatprostatecancerriskloci ‡A Single-Nucleotide Polymorphisms Sequencing Identifies Candidate Functional Variants at Prostate Cancer Risk Loci ‡9 1 | ||
919 | ‡a synergisticinteractionofhoxb13andcip2apredisposestoaggressiveprostatecancer ‡A Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer ‡9 1 | ||
919 | ‡a advantagesofsinglestrandeddnaoverdoublestrandeddnalibrarypreparationforcapturingcellfreetumordnainplasma ‡A Advantages of Single-Stranded DNA Over Double-Stranded DNA Library Preparation for Capturing Cell-Free Tumor DNA in Plasma ‡9 1 | ||
919 | ‡a bioinformaticsanalysisforcirculatingcellfreednaincancer ‡A Bioinformatics Analysis for Circulating Cell-Free DNA in Cancer ‡9 1 | ||
919 | ‡a cellfreednacopynumbervariationsinplasmafromcolorectalcancerpatients ‡A Cell-free DNA copy number variations in plasma from colorectal cancer patients ‡9 1 | ||
919 | ‡a cellfreednamethylomeprofilingbymbdseqwithultralowinput ‡A Cell-free DNA methylome profiling by MBD-seq with ultra-low input ‡9 1 | ||
919 | ‡a cellfreeeccdnasanewtypeofnucleicacidcomponentforliquidbiopsy ‡A Cell-Free eccDNAs: A New Type of Nucleic Acid Component for Liquid Biopsy? ‡9 1 | ||
919 | ‡a crispriscreensrevealadnamethylationmediated3dgenomedependentcausalmechanisminprostatecancer ‡A CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer ‡9 1 | ||
919 | ‡a exosomalmirnasasnovelpharmacodynamicbiomarkersforcancerchemopreventiveagentearlystagetreatmentsinchemicallyinducedmousemodeloflungsquamouscellcarcinoma ‡A Exosomal miRNAs as Novel Pharmacodynamic Biomarkers for Cancer Chemopreventive Agent Early Stage Treatments in Chemically Induced Mouse Model of Lung Squamous Cell Carcinoma. ‡9 1 | ||
919 | ‡a highthroughputscreeningofprostatecancerrisklocibysinglenucleotidepolymorphismssequencing ‡A High-throughput screening of prostate cancer risk loci by single nucleotide polymorphisms sequencing. ‡9 1 | ||
919 | ‡a molecularcharacterizationofcellfreeeccdnasinhumanplasma ‡A Molecular characterization of cell-free eccDNAs in human plasma. ‡9 1 | ||
919 | ‡a multiplexdigitalpcrtodetectamplificationsofspecificandrogenreceptorlociincellfreednaforprognosisofmetastaticcastrationresistantprostatecancer ‡A Multiplex Digital PCR to Detect Amplifications of Specific Androgen Receptor Loci in Cell-Free DNA for Prognosis of Metastatic Castration-Resistant Prostate Cancer ‡9 1 | ||
919 | ‡a nrf2drivenkeap1transcriptioninhumanlungcancer ‡A NRF2-Driven KEAP1 Transcription in Human Lung Cancer ‡9 1 | ||
919 | ‡a plk1induceschromosomalinstabilityandoverridescellcyclecheckpointstodrivetumorigenesis ‡A PLK1 induces chromosomal instability and overrides cell cycle checkpoints to drive tumorigenesis ‡9 1 | ||
919 | ‡a prognosticassociationofplasmacellfreednabasedandrogenreceptoramplificationandcirculatingtumorcellsinprechemotherapymetastaticcastrationresistantprostatecancerpatients ‡A Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients ‡9 1 | ||
919 | ‡a prospectsforclinicaldevelopmentofstat5inhibitorist5002hightranscriptomicspecificityinprostatecancerandlowtoxicityinvivo ‡A Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo ‡9 1 | ||
919 | ‡a singlenucleotidepolymorphismrs13426236contributestoanincreasedprostatecancerriskviaregulatingmlphsplicingvariant4 ‡A Single-nucleotide polymorphism rs13426236 contributes to an increased prostate cancer risk via regulating MLPH splicing variant 4 ‡9 1 | ||
996 | ‡2 ISNI|0000000045915264 | ||
996 | ‡2 J9U|987007451386905171 | ||
996 | ‡2 NSK|000704082 | ||
996 | ‡2 CYT|AC000007537 | ||
996 | ‡2 ISNI|000000006411039X | ||
996 | ‡2 CYT|AC000641465 | ||
996 | ‡2 DNB|133883744 | ||
996 | ‡2 LC|nr 98010980 | ||
996 | ‡2 LC|n 85244557 | ||
996 | ‡2 CYT|AC000641588 | ||
996 | ‡2 DNB|1331837057 | ||
996 | ‡2 NSK|000754545 | ||
996 | ‡2 SUDOC|266969682 | ||
996 | ‡2 CYT|AC000000302 | ||
996 | ‡2 SUDOC|169565114 | ||
996 | ‡2 DNB|1318986788 | ||
996 | ‡2 LC|n 86139480 | ||
996 | ‡2 SUDOC|179399225 | ||
996 | ‡2 CYT|AC000641502 | ||
996 | ‡2 NTA|192665545 | ||
996 | ‡2 BIBSYS|3086216 | ||
996 | ‡2 SUDOC|162018053 | ||
996 | ‡2 CAOONL|ncf10118376 | ||
996 | ‡2 DNB|1200121031 | ||
996 | ‡2 LC|n 85064938 | ||
996 | ‡2 LC|n 2023005750 | ||
996 | ‡2 LC|nr2001012426 | ||
996 | ‡2 CYT|AC000576821 | ||
996 | ‡2 LC|n 81018728 | ||
996 | ‡2 NTA|364154659 | ||
996 | ‡2 SUDOC|139607684 | ||
996 | ‡2 LC|nr 92004492 | ||
996 | ‡2 NSK|000708662 | ||
996 | ‡2 ISNI|0000000063654600 | ||
996 | ‡2 SUDOC|143715690 | ||
996 | ‡2 DNB|1036316769 | ||
996 | ‡2 SUDOC|280930976 | ||
996 | ‡2 LC|n 86099727 | ||
996 | ‡2 SUDOC|170937100 | ||
996 | ‡2 LC|nr 90001829 | ||
996 | ‡2 ISNI|0000000079968567 | ||
996 | ‡2 LC|n 2004101983 | ||
996 | ‡2 ISNI|0000000063720479 | ||
996 | ‡2 NTA|344701581 | ||
996 | ‡2 CAOONL|ncf11558977 | ||
996 | ‡2 LC|n 2008084128 | ||
996 | ‡2 CYT|AC000642098 | ||
996 | ‡2 DNB|1296479498 | ||
996 | ‡2 NSK|000526804 | ||
996 | ‡2 ISNI|0000000054966370 | ||
996 | ‡2 W2Z|14040259 | ||
996 | ‡2 ISNI|000000006383840X | ||
996 | ‡2 J9U|987007426477205171 | ||
996 | ‡2 ISNI|0000000444587093 | ||
996 | ‡2 ISNI|0000000092299142 | ||
996 | ‡2 DNB|17244215X | ||
996 | ‡2 NSK|000274444 | ||
996 | ‡2 ISNI|0000000375860286 | ||
996 | ‡2 NTA|324130457 | ||
996 | ‡2 DNB|142282243 | ||
996 | ‡2 ISNI|0000000064156312 | ||
996 | ‡2 DNB|1324561661 | ||
996 | ‡2 LC|n 85047988 | ||
996 | ‡2 ISNI|0000000063498177 | ||
996 | ‡2 LC|no2021027898 | ||
996 | ‡2 NTA|364154152 | ||
996 | ‡2 DNB|1161102930 | ||
996 | ‡2 LC|no2022120363 | ||
996 | ‡2 LC|n 2016060888 | ||
996 | ‡2 ISNI|0000000063479443 | ||
996 | ‡2 DNB|141040858 | ||
996 | ‡2 ISNI|0000000012441445 | ||
996 | ‡2 DNB|1285267966 | ||
996 | ‡2 CYT|AC000637844 | ||
996 | ‡2 LC|nr 90023298 | ||
996 | ‡2 DNB|1305986873 | ||
996 | ‡2 ISNI|0000000064274239 | ||
996 | ‡2 ISNI|0000000444632552 | ||
996 | ‡2 LC|nr 92001076 | ||
996 | ‡2 NTA|330655167 | ||
996 | ‡2 ISNI|0000000110916926 | ||
996 | ‡2 SUDOC|133831361 | ||
996 | ‡2 J9U|987012945270305171 | ||
996 | ‡2 CYT|AC000611586 | ||
996 | ‡2 PLWABN|9811557967105606 | ||
996 | ‡2 NII|DA08572573 | ||
996 | ‡2 DNB|1148988491 | ||
996 | ‡2 LC|nr 96005228 | ||
996 | ‡2 DNB|112926372X | ||
996 | ‡2 DNB|1304978192 | ||
996 | ‡2 DBC|87097992451313 | ||
996 | ‡2 PTBNP|41206 | ||
996 | ‡2 LC|nr 90014824 | ||
996 | ‡2 ISNI|0000000382728291 | ||
996 | ‡2 DNB|1165895749 | ||
996 | ‡2 ISNI|0000000118148546 | ||
996 | ‡2 CYT|AC000642152 | ||
996 | ‡2 DNB|1045983144 | ||
996 | ‡2 DNB|1112578358 | ||
996 | ‡2 ISNI|0000000507194095 | ||
996 | ‡2 LC|n 84001988 | ||
996 | ‡2 LC|n 82145332 | ||
996 | ‡2 J9U|987007417514205171 | ||
996 | ‡2 ISNI|0000000361099633 | ||
996 | ‡2 LC|no 00018618 | ||
996 | ‡2 LC|n 79000010 | ||
996 | ‡2 LC|n 84039438 | ||
996 | ‡2 LC|no2015168039 | ||
996 | ‡2 LC|n 2017015935 | ||
996 | ‡2 PLWABN|9810551358205606 | ||
996 | ‡2 ISNI|0000000083361362 | ||
996 | ‡2 CYT|AC000658658 | ||
996 | ‡2 SUDOC|236889346 | ||
996 | ‡2 LC|n 92107826 | ||
996 | ‡2 LC|n 2018071095 | ||
996 | ‡2 NKC|xx0240072 | ||
996 | ‡2 CAOONL|ncf11959997 | ||
996 | ‡2 PLWABN|9811552473905606 | ||
996 | ‡2 BNF|17178829 | ||
996 | ‡2 LC|n 2016009617 | ||
996 | ‡2 ISNI|0000000028390443 | ||
996 | ‡2 ISNI|0000000047014056 | ||
996 | ‡2 NTA|142803138 | ||
996 | ‡2 ISNI|0000000051346299 | ||
996 | ‡2 ISNI|0000000077385851 | ||
996 | ‡2 CYT|AC000641826 | ||
996 | ‡2 DNB|1264144067 | ||
996 | ‡2 CYT|AC000209028 | ||
996 | ‡2 SUDOC|117598852 | ||
996 | ‡2 CYT|AC000208155 | ||
996 | ‡2 DNB|1339171309 | ||
996 | ‡2 DNB|1047548844 | ||
996 | ‡2 J9U|987007334964405171 | ||
996 | ‡2 CYT|AC000000241 | ||
996 | ‡2 CYT|AC000641415 | ||
996 | ‡2 LC|no 98069023 | ||
996 | ‡2 DNB|1065413297 | ||
996 | ‡2 ISNI|0000000063653253 | ||
996 | ‡2 ISNI|0000000081454979 | ||
996 | ‡2 NUKAT|n 2018044033 | ||
996 | ‡2 NTA|329338390 | ||
996 | ‡2 DNB|1017366799 | ||
996 | ‡2 DNB|125792069 | ||
996 | ‡2 DNB|119012707 | ||
996 | ‡2 ISNI|0000000064185738 | ||
996 | ‡2 CYT|AC000637106 | ||
996 | ‡2 PLWABN|9812033285705606 | ||
996 | ‡2 NSK|000261043 | ||
996 | ‡2 LC|nr 90022978 | ||
996 | ‡2 DNB|1217178341 | ||
996 | ‡2 ISNI|0000000051463137 | ||
996 | ‡2 NKC|vse20191053357 | ||
996 | ‡2 LC|n 85173675 | ||
996 | ‡2 ISNI|0000000114213507 | ||
996 | ‡2 NTA|301865833 | ||
996 | ‡2 LC|n 78045732 | ||
996 | ‡2 ISNI|000000007739095X | ||
996 | ‡2 DNB|1337570052 | ||
996 | ‡2 ISNI|0000000091795769 | ||
996 | ‡2 NII|DA11704231 | ||
996 | ‡2 PLWABN|9810590627605606 | ||
996 | ‡2 LC|n 2021008986 | ||
996 | ‡2 ISNI|000000006326141X | ||
996 | ‡2 DNB|1259426181 | ||
996 | ‡2 DNB|1148111727 | ||
996 | ‡2 CYT|AC000658707 | ||
996 | ‡2 ISNI|0000000063728673 | ||
996 | ‡2 NSK|000737840 | ||
996 | ‡2 LC|n 2011004808 | ||
996 | ‡2 CYT|AC000007796 | ||
996 | ‡2 ISNI|0000000083755492 | ||
996 | ‡2 RERO|A000079518 | ||
996 | ‡2 LC|no2023075011 | ||
996 | ‡2 BIBSYS|1542227326599 | ||
996 | ‡2 LC|n 85299274 | ||
996 | ‡2 LC|no2008133619 | ||
996 | ‡2 DNB|1276078129 | ||
996 | ‡2 LC|n 2016019407 | ||
996 | ‡2 DNB|1339098539 | ||
996 | ‡2 LC|n 85262462 | ||
996 | ‡2 CYT|AC000517396 | ||
996 | ‡2 SUDOC|260070270 | ||
996 | ‡2 DNB|1138570001 | ||
996 | ‡2 NTA|364154063 | ||
996 | ‡2 ISNI|0000000120329581 | ||
996 | ‡2 LC|n 82135671 | ||
996 | ‡2 NUKAT|n 2012100799 | ||
996 | ‡2 NSK|000582802 | ||
996 | ‡2 LC|n 88259741 | ||
996 | ‡2 J9U|987007337463005171 | ||
996 | ‡2 LC|n 2023057601 | ||
996 | ‡2 ISNI|0000000388284740 | ||
996 | ‡2 ISNI|0000000064296307 | ||
996 | ‡2 DNB|130522503 | ||
996 | ‡2 LC|no2014139923 | ||
996 | ‡2 J9U|987007342554905171 | ||
996 | ‡2 NUKAT|n 2021201255 | ||
996 | ‡2 ISNI|0000000063562175 | ||
996 | ‡2 LC|n 88658764 | ||
996 | ‡2 ISNI|0000000054449314 | ||
996 | ‡2 DNB|1117115275 | ||
996 | ‡2 ISNI|0000000063570773 | ||
996 | ‡2 DNB|128757949 | ||
996 | ‡2 LC|nr2001011392 | ||
996 | ‡2 DNB|1190191873 | ||
996 | ‡2 DNB|1311319298 | ||
996 | ‡2 CAOONL|ncf11530748 | ||
996 | ‡2 DNB|1236503813 | ||
996 | ‡2 ISNI|0000000050862718 | ||
996 | ‡2 BIBSYS|14040259 | ||
996 | ‡2 J9U|987007317015705171 | ||
996 | ‡2 NKC|jx20140217004 | ||
996 | ‡2 DNB|116925909X | ||
996 | ‡2 CYT|AC000210463 | ||
996 | ‡2 PLWABN|9813208248605606 | ||
996 | ‡2 NTA|364154683 | ||
996 | ‡2 DNB|1022768778 | ||
996 | ‡2 ISNI|0000000064150922 | ||
996 | ‡2 DNB|1266022562 | ||
996 | ‡2 LC|no2021126906 | ||
996 | ‡2 ISNI|0000000063858865 | ||
996 | ‡2 ISNI|0000000069723267 | ||
996 | ‡2 SUDOC|219821801 | ||
996 | ‡2 ISNI|0000000063455564 | ||
996 | ‡2 LC|no2014107414 | ||
996 | ‡2 SUDOC|225010704 | ||
996 | ‡2 ISNI|0000000135605948 | ||
996 | ‡2 LC|n 2009012221 | ||
996 | ‡2 ISNI|0000000369556085 | ||
996 | ‡2 DNB|122078852X | ||
996 | ‡2 LC|no2007097562 | ||
996 | ‡2 BNF|17748641 | ||
996 | ‡2 RERO|A003957507 | ||
996 | ‡2 DNB|121164720X | ||
996 | ‡2 SUDOC|184227518 | ||
996 | ‡2 PLWABN|9811766132105606 | ||
996 | ‡2 LC|n 83126033 | ||
996 | ‡2 ISNI|0000000063622481 | ||
996 | ‡2 NSK|000337340 | ||
996 | ‡2 DNB|1265034885 | ||
996 | ‡2 ISNI|0000000064212097 | ||
996 | ‡2 LC|no2018150258 | ||
996 | ‡2 NTA|256253889 | ||
996 | ‡2 LC|n 89118458 | ||
996 | ‡2 ISNI|0000000079968081 | ||
996 | ‡2 NUKAT|n 2012172983 | ||
996 | ‡2 ISNI|0000000063983076 | ||
996 | ‡2 LC|n 84073907 | ||
996 | ‡2 LC|no2021143815 | ||
996 | ‡2 DNB|1280153547 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |